Skip to main content
Equibles
DOCS logo

DOCS · Doximity, Inc.

Track DOCS — free

Use DOCS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DOCS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.75 +0.81 (+3.25%) At close · Aug 19
Market Cap
$4.53B
Shares
178.25M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$25.75 Open$24.95 Day$24.81–25.92 52W close$18.01–75.12 Avg vol 30d6.2M Short int24.6M · 13.8% float · 8.0d Short vol52% Last earningsAug 6, 2026 DataJun 2021–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 11 wks
FQ2-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −16%
      below
      Price vs 50-day avg +17%
      above
      RSI (14) 60
      neutral
      MACD trend Positive
      52-week position 14%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return +26%
      trailing
      6-month return +3%
      trailing
      YTD return −42%
      this year
      Relative strength −9%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $22 › 200d $31 — 200d above 50d
      Institutional flow Distributing
      -16% holders QoQ · +42 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      13.79% of float · ▲ +18.5% MoM · 8.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      358 holders — mid 3-yr range
      Squeeze score 82
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +13%
      Y/Y
      Gross margin 89%
      contracting
      EPS growth −12%
      Y/Y
      Free cash flow $326.5M
      Valuation P/E 30.2
      below peers
      Buyback $400.9M
      remaining
      Balance sheet $219.2M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 63%
      annualized · 1-yr
      Max drawdown −76%
      past year
      ATR 7.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 8 of last 8
      Latest guidance · from the 8-K filed Aug 6, 2026
      fiscal second quarter ending September 30, 2026
      Revenue $170M – $171M
      prior qtr $156.62M midpoint +8.9% QoQ
      Adjusted EBITDA $80.5M – $81.5M
      fiscal year ending March 31, 2027
      Revenue Initiated $671M – $681M
      prior FY $644.86M midpoint +4.8% Y/Y
      Adjusted EBITDA Initiated $309M – $329M
      Prior guidance period ended · from the Earnings Call filed Mar 31, 2024
      Revenue · first fiscal quarter of 2025 $119.5M – $120.5M
      Revenue · full fiscal year 2025 $506M – $518M
      Guided vs delivered · last 8 settled
      Revenue fiscal third quarter ending December 31, 2025
      guided $180M – $181M
      $185.05M Beat +2.5%
      Revenue fiscal year ending March 31, 2026
      guided $640M – $646M
      $644.86M In line
      Revenue fiscal second quarter ending September 30, 2025
      guided $157M – $158M
      $168.53M Beat +7.0%
      Revenue first fiscal quarter of 2025
      guided $119.5M – $120.5M
      $126.68M Beat +5.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −16% Bearish
      Price vs 50-day avg
      +17% Bullish
      RSI (14)
      60 Neutral
      MACD trend
      Positive Bullish
      52-week position
      14% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $22 › 200d $31 — 200d above 50d
      Institutional flow Distributing
      -16% holders QoQ · +42 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      13.79% of float · ▲ +18.5% MoM · 8.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      358 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $18 Now $26 · 14% Range high $75
      vs 200-day avg -16% vs 50-day avg +17%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Net cash provided by operating activities 41.99M
      -62K Purchases of property and equipment
      -2.32M Internal-use software development costs
      = Free cash flow 39.6M
      Non-GAAP gross margin non-GAAP 87.5% Three Months Ended June 30 —
      Non-GAAP gross profit non-GAAP $137.05M Three Months Ended June 30 —
      GAAP → non-GAAP reconciliation
      GAAP GAAP gross profit 132.93M
      +3.19M Stock-based compensation
      +935K Amortization of acquired intangibles
      = Non-GAAP gross profit 137.05M
      Non-GAAP net income non-GAAP $54.95M Three Months Ended June 30 —
      GAAP → non-GAAP reconciliation
      GAAP GAAP net income 24.32M
      +0K Acquisition and other related expenses
      +36.75M Stock-based compensation
      +1.94M Amortization of acquired intangibles
      +90K Change in fair value of contingent earn-out consideration liability
      -8.14M Income tax effect of non-GAAP adjustments
      = Non-GAAP net income 54.95M
      Non-GAAP net income margin non-GAAP 35.1% Three Months Ended June 30 —
      Non-GAAP operating income non-GAAP $72.43M Three Months Ended June 30 —
      GAAP → non-GAAP reconciliation
      GAAP GAAP operating income 33.64M
      +0K Acquisition and other related expenses
      +36.75M Stock-based compensation
      +1.94M Amortization of acquired intangibles
      +90K Change in fair value of contingent earn-out consideration liability
      = Non-GAAP operating income 72.43M
      active prescribers 800,000 Q4 fiscal 2026 —
      Operating cash flow $326.5M Fiscal Year 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      DOCS
      Doximity, Inc.
      this stock
      		$4.53B -41.8% +13.1% 30.2 13.8%
      VEEV
      Veeva Systems Inc
      		 $39.43B +12.4% +28.1% 43.0 4.5%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $11.77B +58.4% +28.2% 36.1 4.2%
      TEM
      Tempus AI, Inc.
      		 $8.91B +3.7% +83.4% — 18.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      358
      % held
      73.0%
      Net QoQ
      +2.1M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      367
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      24.6M
      Days to cover
      8.0d
      Change
      +3.8M sh
      View
      Short Volume
      Short vol %
      52%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      3
      Value
      $67
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      38.3%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Jonathan Jackson
      Amount
      $15.0K–$50.0K
      Traded
      Nov 6, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $644.9M
      Net income (FY)
      $196.1M
      EPS diluted
      $0.98
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $400.9M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $44.1K
      Shares
      1.8K
      Filed
      Aug 13, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Aug 27, 2026
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      Doximity Announces Fiscal 2027 Fi…
      Published
      Aug 6, 2026
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      DOCS +3.0% +25.7% +2.6% +23.2% -41.9%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY +3.5% +22.8% -9.0% +20.2% -54.6%

      Capital returns

      Buyback program · as of Jun 30, 2026
      Authorized
      $500.00M
      Spent (derived)
      $99.10M
      Remaining
      $400.90M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1516513 CUSIP 26622P107 13F (30d) 324 filings 319 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)